We considered such limitations and produced preliminary observations on the role of PGC-1α in an optimized preclinical model of cancer cachexia adopting both middle (14 months) and aged (22 months) mice bearing the LLC tumor and receiving doxorubicin (see Appendix A for details). This evidence concerns the gene PPARGC1A and cancer.